Who is sponsoring NCT07078240?

NCT07078240 is sponsored by Tan Tock Seng Hospital.

What drugs are being tested in NCT07078240?

Interventions in NCT07078240: Falls risk - Artificial Intelligence Recommender (FAIR), modified Western Health Falls Risk Assessment Tool (mWHeFRA).

What condition does NCT07078240 study?

NCT07078240 studies Falls Risk.

Is NCT07078240 still recruiting?

NCT07078240 is currently not yet recruiting. Last updated 22 July 2025.

Last reviewed 2025-07-22 · How we verify

NCT07078240

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Examining Nurses' Trust and Acceptance of FAIR, an AI-powered Falls Risk Recommender

Not yet recruiting NA Last updated 22 July 2025

What this trial tests

NA trial testing Falls risk - Artificial Intelligence Recommender (FAIR) in Falls Risk in 60 participants. Not yet recruiting.

Timeline

1 January 2027

Primary endpoint
31 December 2027

30 June 2029

Quick facts

Lead sponsor	Tan Tock Seng Hospital
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	60
Start date	1 January 2027
Primary completion	31 December 2027
Estimated completion	30 June 2029

Drugs / interventions tested

Falls risk - Artificial Intelligence Recommender (FAIR)
modified Western Health Falls Risk Assessment Tool (mWHeFRA)

Conditions studied

Falls Risk — all drugs for Falls Risk →

Sponsor

Tan Tock Seng Hospital

Who can join

Eligibility, any sex, with Falls Risk. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An exploratory mixed-method study will be conducted to test acceptance and trust of an AI-powered falls risk predictor system by inpatient hospital nurses

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tan Tock Seng Hospital trials

Trials by the same sponsor.

NCT07257341 — Pilot Study of Normative Range of Field of Binocular Single Vision in Adults in Singapore · recruiting
NCT07151729 — Use of Anodal tDCS to Enhance Upper Limb Recovery in Stroke · NA · recruiting
NCT07122752 — Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy · active not recruiting
NCT07255859 — CRYSTALSIGHT Cohort 2.0 · NA · recruiting
NCT07255885 — CRYSTALSIGHT: ''Cohort 1.5" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07078240 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tan Tock Seng Hospital
Last refreshed: 22 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07078240.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing